Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Excessive Daytime Somnolence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04299009
What this trial is testing

Bright Light Therapy for Residual Daytime Symptoms Associated With Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep Apnea
VA Office of Research and Development 15
Testing effectiveness (Phase 2)Study completedNCT03881852
What this trial is testing

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

Who this might be right for
NarcolepsyCataplexy NarcolepsyExcessive Sleepiness
Axsome Therapeutics, Inc. 21
Not applicableNot Yet RecruitingNCT07522021
What this trial is testing

Daytime vs Evening Rehabilitation in Lumbar Disc Herniation Patients at High Risk for Obstructive Sleep Apnea

Who this might be right for
Lumbar Disc HerniationObstructive Sleep Apnea Risk Management
Mardin Artuklu University 60
Not applicableUnknownNCT00497120
What this trial is testing

A Combined Surgical and Medical Approach in Mild Sleep Apnea

Who this might be right for
Sleep Apnea
University Hospital, Antwerp
Large-scale testing (Phase 3)Study completedNCT05113745
What this trial is testing

Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 68
Large-scale testing (Phase 3)Looking for participantsNCT07598708
What this trial is testing

Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited 222
Not applicableStudy completedNCT04942574
What this trial is testing

Voice Biomarkers to Predict Excessive Daytime Sleepiness

Who this might be right for
Sleep Deprivation
University Hospital, Bordeaux 30
Large-scale testing (Phase 3)Study completedNCT02720744
What this trial is testing

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Who this might be right for
Excessive Daytime SleepinessCataplexyNarcolepsy
Avadel 212
Post-approval studies (Phase 4)Study completedNCT00731770
What this trial is testing

Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep

Who this might be right for
COPD
Milton S. Hershey Medical Center 10
Large-scale testing (Phase 3)Study completedNCT00228553
What this trial is testing

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Who this might be right for
Excessive Daytime SleepinessNarcolepsyObstructive Sleep Apnea/Hypopnea Syndrome+1 more
Cephalon 743
Testing effectiveness (Phase 2)Study completedNCT03624920
What this trial is testing

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

Who this might be right for
Parkinson Disease
Theranexus 77
Early research (Phase 1)Study completedNCT01124851
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

Who this might be right for
Sleep Disorder
Abbott 36
Large-scale testing (Phase 3)Study completedNCT02151253
What this trial is testing

Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia

Who this might be right for
NocturiaDaytime Sleepiness
Duke University 81
Testing effectiveness (Phase 2)Ended earlyNCT01348607
What this trial is testing

Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

Who this might be right for
Central Nervous System Tumor, PediatricFatigueSpecific Disorders of Sleep
University of South Florida 1
Not applicableEnrolling By InvitationNCT06336525
What this trial is testing

Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.

Who this might be right for
Sleep ApneaInsomniaSleep Deprivation+3 more
Brigham and Women's Hospital 3,680
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Not applicableStudy completedNCT02027142
What this trial is testing

Sleep Quality, Daytime Sleepiness and Insomnia in Patients With Endometriosis: a Case-control Study.

Who this might be right for
EndometriosisSleep
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 290
Large-scale testing (Phase 3)Study completedNCT01067235
What this trial is testing

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Bioprojet 14
Large-scale testing (Phase 3)Study completedNCT06103825
What this trial is testing

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)

Who this might be right for
Sleep Apnea, ObstructiveExcessive Daytime Sleepiness
Ignis Therapeutics (Suzhou) Limited 204
Testing effectiveness (Phase 2)Study completedNCT01681121
What this trial is testing

The Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

Who this might be right for
Narcolepsy
Jazz Pharmaceuticals 93
Next Page